ReviewCurrent infectious disease reports2026
The Infection Timeline in Solid Organ Transplantation: Lessons from the Swiss Transplant Cohort.
Review in Current infectious disease reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose of Review: Understanding the timeline of infections after solid organ transplantation is essential for prevention, diagnosis, and appropriate empiric therapy. Preventive strategies have substantially reduced some infections, while the increasing prevalence of multidrug-resistant organisms challenges traditional empiric approaches. Recent Findings: Contemporary epidemiology demonstrates a shift in post-transplant infections. Opportunistic infections have become uncommon, while bacterial infections now predominate, particularly those caused by Enterobacterales, non-fermenting gram-negative bacilli, and gram-positive pathogens. The success in the control of opportunistic infections is increasingly challenged by the rise of multidrug-resistant organisms. Summary: Strengthened strategies to prevent bacterial infections, especially those due to multidrug-resistant pathogens, are needed in solid organ transplant recipients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.